Grin logo
en de es fr
Shop
GRIN Website
Publish your texts - enjoy our full service for authors
Go to shop › Communications - Public Relations, Advertising, Marketing, Social Media

Mergers and Acquisitions in the Global Pharmaceutical Industry

Title: Mergers and Acquisitions in the Global Pharmaceutical Industry

Project Report , 2006 , 27 Pages , Grade: 65 % - B

Autor:in: Mennen (Author), Abayomi (Author), Jian (Author), Mead (Author), Zhou (Author)

Communications - Public Relations, Advertising, Marketing, Social Media
Excerpt & Details   Look inside the ebook
Summary Excerpt Details

Mergers and acquisitions are of major importance in the pharmaceutical industry. In order to evaluate the dynamics of this particular industry, this paper critically evaluates the pre- and post- merger situation of GlaxoSmithKline concerning its ready-access to markets, know-how and management capability. Furthermore, strengths and weaknesses and merger’s outcomes will be outlined. Critical push and pull factors affecting M&A activity in North America will be analysed, using Pfizer and Pharmacia as an example. In addition, general reasons for M&A failure in the pharmaceutical industry will be illustrated focussing on the M&A activity of GlaxoSmithKline. Finally, using two global pharmaceutical players (GSK and Astrazeneca), the merits and demerits of the McKinsey’s five step programme will be discussed.

Excerpt


Inhaltsverzeichnis (Table of Contents)

  • ABSTRACT
  • CONTENTS
  • INTRODUCTION
  • QUESTION ONE
  • QUESTION TWO
  • QUESTION THREE
  • QUESTION FOUR
  • CONCLUSIONS AND RECOMMENDATIONS
  • References
  • Appendices
    • APPENDIX 1: Porter's Five Forces Model
    • APPENDIX 2: Global Pharmaceutical Industry - Overview
    • APPENDIX 3: SWOT Analysis – Pre-merger (SKB & GW)
    • APPENDIX 4: SWOT Analysis – Post-merger (GSK) & Outcomes
    • APPENDIX 5: Pharmaceutical Relationship Alternatives
    • APPENDIX: 6 Sales Growth of Astrazeneca - Pre & Post-Merger
    • APPENDIX 7: McKinsey's 5-Step Table

Zielsetzung und Themenschwerpunkte (Objectives and Key Themes)

This paper aims to analyse mergers and acquisitions in the global pharmaceutical industry since the 1990's through the lens of strategy management. The paper focuses on critical evaluation of the pre- and post-merger situation of GlaxoSmithKline, examining its access to markets, know-how, and management capabilities, as well as identifying the strengths, weaknesses, and outcomes of the merger. Additionally, it analyzes push and pull factors influencing M&A activity in North America, using Pfizer and Pharmacia as an example. The paper also explores reasons for M&A failure in the pharmaceutical industry, particularly focusing on the M&A activities of GlaxoSmithKline. Finally, the merits and demerits of McKinsey's five-step program are discussed using global pharmaceutical players GSK and AstraZeneca.

  • Mergers and acquisitions in the global pharmaceutical industry
  • Critical evaluation of GlaxoSmithKline's pre- and post-merger situation
  • Push and pull factors driving M&A activity in North America
  • Reasons for M&A failure in the pharmaceutical industry
  • Merits and demerits of McKinsey's five-step program

Zusammenfassung der Kapitel (Chapter Summaries)

  • INTRODUCTION: This chapter introduces the global pharmaceutical industry, highlighting its profitability and dominance by a handful of multinational companies. It uses Porter's five forces analysis to understand the competitive landscape and presents a brief overview of the industry's structure and key players.
  • QUESTION ONE: This chapter focuses on GlaxoSmithKline, formed through the merger of Glaxo Wellcome and SmithKline Beecham in 2000. It explores the reasons behind the merger, including the underperformance of Glaxo Wellcome's shares and SmithKline Beecham's need to expand its drug range. A SWOT analysis is conducted to outline the internal strengths and weaknesses of the companies before and after the merger.

Schlüsselwörter (Keywords)

The key terms and concepts explored in this paper include mergers and acquisitions, pharmaceutical industry, global strategy, market access, know-how, management capability, SWOT analysis, push and pull factors, M&A failure, McKinsey's five-step program, and global pharmaceutical players like GlaxoSmithKline, AstraZeneca, and Pfizer.

Excerpt out of 27 pages  - scroll top

Details

Title
Mergers and Acquisitions in the Global Pharmaceutical Industry
College
University of Sunderland
Course
Global Corporate Strategy
Grade
65 % - B
Authors
Mennen (Author), Abayomi (Author), Jian (Author), Mead (Author), Zhou (Author)
Publication Year
2006
Pages
27
Catalog Number
V145495
ISBN (eBook)
9783640779765
ISBN (Book)
9783640780587
Language
English
Tags
pre- and post- merger situation GlaxoSmithKline Pfizer Astrazeneca ready-access to markets Push and Pull factors affecting M&A McKinsey’s five step programme Porter’s Five Forces Model SWOT Analysis
Product Safety
GRIN Publishing GmbH
Quote paper
Mennen (Author), Abayomi (Author), Jian (Author), Mead (Author), Zhou (Author), 2006, Mergers and Acquisitions in the Global Pharmaceutical Industry, Munich, GRIN Verlag, https://www.grin.com/document/145495
Look inside the ebook
  • Depending on your browser, you might see this message in place of the failed image.
  • https://cdn.openpublishing.com/images/brand/1/preview_popup_advertising.jpg
  • Depending on your browser, you might see this message in place of the failed image.
  • Depending on your browser, you might see this message in place of the failed image.
  • Depending on your browser, you might see this message in place of the failed image.
  • Depending on your browser, you might see this message in place of the failed image.
  • Depending on your browser, you might see this message in place of the failed image.
  • Depending on your browser, you might see this message in place of the failed image.
  • Depending on your browser, you might see this message in place of the failed image.
  • Depending on your browser, you might see this message in place of the failed image.
Excerpt from  27  pages
Grin logo
  • Grin.com
  • Payment & Shipping
  • Contact
  • Privacy
  • Terms
  • Imprint